Clinical Trials
19 trialsNCT02834013 2026-05-13
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05075980 2026-04-13
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Mayo Clinic
Phase 2 Active not recruiting
NCT07512466 2026-04-06
Evaluation of Endoscopic Management of Sinonasal Tumors In Difficult Anatomical Locations
Assiut University
Phase NA Not yet recruiting
NCT00707473 2026-03-05
Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06940180 2025-06-26
Toripalimab With Chemotherapy for Sinus Cancer
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT04788264 2025-05-22
Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment
Thomas Jefferson University
Phase NA Completed
NCT03274414 2025-05-16
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04162873 2025-02-12
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
University of Utah
Phase 2 Terminated
NCT05992610 2023-08-15
iCHRTL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase NA Unknown
NCT04374448 2022-11-14
NIRFICG
St. Paul's Sinus Centre
Phase NA Unknown
NCT05114707 2021-11-10
Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses
Sun Yat-sen University
Phase 2 Unknown
NCT03096808 2021-10-26
Adaptive Radiotherapy for Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01469429 2020-02-20
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Ohio State University Comprehensive Cancer Center
Phase 1/2 Completed
NCT03049358 2019-02-05
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer
Stanford University
Phase NA Terminated
NCT00117572 2018-04-09
DeCIDE
University of Chicago
Phase 3 Completed
NCT00462735 2018-03-13
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00003489 2017-11-21
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00970502 2017-04-10
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT00347256 2008-12-10
Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer
University of Tennessee
Phase NA Withdrawn